Working groups
Professor Brendan Crabb AC PhD FAA FAHMS FASM is an infectious disease researcher with a special interest in malaria. His research group develops and exploits genetic approaches to better understand malaria parasite biology, principally to help prioritise vaccine and drug targets.
Although a molecular scientist by training, Professor Crabb’s interests include addressing technical and non-technical barriers to maternal, newborn and child health in the developing world. In recent years, under the banner of Healthy Mothers Healthy Babies, he helped establish a major research field site in East New Britain in Papua New Guinea, principally to identify the underlying drivers (including malaria) of low birth weight and stunting in relatively calorie-rich, yet resource-poor settings.
Since 2008 he has been the Director and CEO of the Macfarlane Burnet Institute for Medical Research and Public Health (Burnet Institute), a research institute that has a focus on infectious diseases and women's, children's and adolescents' health, especially for populations most in need. Burnet has played a major role in the COVID-19 pandemic, including advising governments and advocating strongly for public health action.
Professor Crabb is President of both the Australian Global Health Alliance and the Pacific Friends of Global Health, bodies that advocate for better health equity. He is the past-President of the Association of Australian Medical Research Institutes (AAMRI), the peak body for independent medical research Institutes in Australia. Professor Crabb has played critical roles in transformative government policy and funding initiatives, including in the generation of the $20b Medical Research Future Fund.
He is currently a Fellow of the Australian Academy of Science (FAA), a Fellow of the Australian Academy of Health and Medical Sciences (FAHMS) and of the Australian Society for Microbiology (FASM). He served on the governing Council of the National Health and Medical Research Council (NHMRC) of Australia from 2016 - 2021. Internationally, he currently serves on the International Advisory Boards of the Sanger Institute (UK) and on the WHO Malaria Vaccine Advisory Committee (MALVAC) in Geneva. Professor Crabb was the Co-Founder of the 1st Malaria World Congress and of the Molecular Approaches to Malaria Conferences.
Prior to 2008, Professor Crabb was a Senior Principal Research Fellow in the NHMRC and an International Fellow of the Howard Hughes Medical Institute in the US. He is an experienced educator having been a full-time teaching and research academic at the University of Melbourne (1996-2000) and has been immersed in education at secondary and tertiary levels ever since.
In 2015, he was awarded a Companion of the Order of Australia, Australia’s highest civilian honour, in 2019 he received the GSK Award for Research Excellence and in 2020 he was awarded the Global Citizen Prize: Australia’s Hero Award.
2020 (1)
The Medical Journal of Australia
Michelle J. L. Scoullar, Gabriela Khoury, S. S. Majumdar, Emma Tippett, Brendan S. Crabb
PLOS Global Public Health
Brendan S. Crabb, S. S. Majumdar
Nature Communications
Madeline G. Dans, Coralie Boulet, Somya Mehra, Zahra Razook, Dawson B. Ling, Thorey K. Jonsdottir, Alyssa E. Barry, Brendan S. Crabb, Paul R. Gilson
Drugs are the main weapons used to combat malaria infection. However, parasites are becoming resistant and new medicines and drug targets are needed.
A collaborative research program aimed at providing life-saving health care for women and children in Papua New Guinea.
A whole of institute initiative that brings together Burnet’s multi-disciplinary skills to tackle the complex challenges of pandemics and health emergencies caused by infectious diseases.
Drugs are the main weapons used to combat malaria infection, but parasites are becoming resistant and new medicines and drug targets are needed.
We work with medicinal chemists to develop new antimalarials that are effective against already multi-drug resistant parasites.